多发性硬化患者癌症风险的10年全国回顾性队列研究
本文为期刊俱乐部评论,讨论Pierret等人关于多发性硬化(MS)患者癌症风险的研究。此前MS与癌症风险关系不明确,该研究显示MS患者癌症风险轻度升高,尤其是泌尿生殖系统癌症。
要点
- MS患者癌症风险轻度升高,尤其泌尿生殖系统癌症。
- 此前MS与癌症风险关系不明确,研究填补知识空白。
- 理解MS对癌症易感性的影响有助于评估治疗安全。
核心结论
- MS患者癌症风险轻度升高,尤其是泌尿生殖系统癌症。
研究设计与样本
- 评论Pierret等人的10年全国回顾性队列研究。
主要发现
- MS患者癌症风险轻度升高,尤其泌尿生殖系统癌症。
临床怎么用
- 关注MS患者癌症风险,尤其泌尿生殖系统癌症,以评估治疗安全。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This journal club article discusses the strengths and limitations of a study from Pierret et al., which examined cancer risk for patients with multiple sclerosis (MS). Before this study, the relationship between MS and cancer risk was unclear because some studies suggested an increased risk while others indicated a decreased risk, highlighting a significant knowledge gap in understanding this complex connection. It is essential to understand how MS may influence cancer susceptibility to assess treatment safety and improve patient care. This study demonstrated that cancer risk, especially for urogenital cancers, was modestly elevated in people with MS.
引用
- Jia A, Price TR, Rosner J, et al. Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study. Neurology. 2025. PMID: 40472310. doi:10.1212/WNL.0000000000213663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。